Showing results (21-30 of 98) with videos related to
Sort By:
Pageof 10
International Journal of Radiation Oncology, Biology, Physics|June 28, 2003
A zero PSA slope in posttreatment prostate-specific antigen supports cure of patients with long-term follow-up after external beam radiotherapy for localized prostate cancerRobert Takamiya, Vivian Weinberg, C Dale Young, et al.Neuro-Oncology|October 26, 2012
Relationship of glioblastoma multiforme to the subventricular zone is associated with survivalNazia F Jafri, Jennifer L Clarke, Vivian Weinberg, et al.Radiation Oncology (London, England)|January 22, 2016
Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancerMekhail Anwar, Vivian Weinberg, Zachary Seymour, et al.International Journal of Radiation Oncology, Biology, Physics|March 7, 2006
Three-dimensional conformal external beam radiotherapy compared with permanent prostate implantation in low-risk prostate cancer based on endorectal magnetic resonance spectroscopy imaging and prostate-specific antigen levelBarby Pickett, John Kurhanewicz, Jean Pouliot, et al.Radiation Oncology (London, England)|February 4, 2014
Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadirMekhail Anwar, Vivian Weinberg, Albert J Chang, et al.Clinical Genitourinary Cancer|October 10, 2009
The mechanism of action of estrogen in castration-resistant prostate cancer: clues from hormone levelsRahul Aggarwal, Vivian Weinberg, Eric J Small, et al.Journal of Contemporary Brachytherapy|August 7, 2014
Pre-plan parameters predict post-implant D90 ≥ 140 Gy for (125)I permanent prostate implantsJes Alexander, Vivian Weinberg, Alexander R Gottschalk, et al.International Journal of Radiation Oncology, Biology, Physics|December 19, 2012
The residual setup errors of different IGRT alignment procedures for head and neck IMRT and the resulting dosimetric impactPierre Graff, Neil Kirby, Vivian Weinberg, et al.Cancer|June 1, 2006
Combination immunotherapy with prostatic acid phosphatase pulsed antigen-presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapyBrian I Rini, Vivian Weinberg, Lawrence Fong, et al.International Journal of Radiation Oncology, Biology, Physics|March 17, 2010
Dosimetric evaluation of automatic segmentation for adaptive IMRT for head-and-neck cancerStuart Y Tsuji, Andrew Hwang, Vivian Weinberg, et al.Pageof 10